Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akari Therapeutics PLC (NASDAQ:AKTX)

4.00
Delayed Data
As of 12:53pm ET
 -0.135 / -3.27%
Today’s Change
3.18
Today|||52-Week Range
22.20
-43.25%
Year-to-Date

Today’s Trading

Previous close4.13
Today’s open4.13
Day’s range3.94 - 4.13
Volume132,687
Average volume (3 months)415,843
Market cap$63.0M
Data as of 12:53pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+60.20%
Earnings growth (this year)-12,850.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
KMPHKemPharm Inc-0.01-0.16%
PSDVpSivida Corp+0.01+0.94%
ALTAltimmune Inc-0.03-1.85%
HSGXHistogenics Corp+0.04+2.21%
Data as of 1:08pm ET, 12/15/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$0.00
Annual profit (last year)-$18.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
David Horn Solomon
Chief Operating Officer &
Director
Clive Stuart Richardson
Corporate headquarters
London, London & South East

Forecasts